Dawn L. Hershman
Columbia University Medical Center
Publications 604
#1Melissa Beauchemin (Columbia University)H-Index: 3
#2Lillian SungH-Index: 45
Last.Rebecca Schnall (Columbia University)H-Index: 18
view all 6 authors...
Purpose Prescribing guideline-recommended anti-emetics is an effective strategy to prevent CINV. However, the rate of guideline-concordant care is not well-understood. The purpose of this study was to describe the proportion of pediatric, adolescent, and young adult patients receiving HEC or MEC who received guideline-concordant antiemetic prophylaxis for acute CINV and to identify potential predictors of guideline-concordant antiemetic prophylaxis.
#1Dawn L. Hershman (CUMC: Columbia University Medical Center)H-Index: 58
#2Melissa K. Accordino (CUMC: Columbia University Medical Center)H-Index: 7
Last.Jason D. Wright (CUMC: Columbia University Medical Center)H-Index: 39
view all 11 authors...
#1Jennifer H. KuoH-Index: 6
#2Yongmei HuangH-Index: 9
Last.Jason D. WrightH-Index: 39
view all 7 authors...
#1Brett E. Youngerman (CUMC: Columbia University Medical Center)H-Index: 11
#2Evan F. Joiner (CUMC: Columbia University Medical Center)H-Index: 1
Last.Jeffrey N. Bruce (CUMC: Columbia University Medical Center)H-Index: 18
view all 10 authors...
Background Evidence supporting routine postoperative antiepileptic drug (AED) prophylaxis following oncologic neurosurgery is limited, and actual practice patterns are largely unknown beyond survey data.
#1Ian M. KronishH-Index: 26
#2Ying Kuen CheungH-Index: 17
Last.Karina W. DavidsonH-Index: 42
view all 11 authors...
Purpose: Little is known about the effectiveness of bright white light therapy (BWL) for depressive symptoms in cancer survivors, many of whom prefer non-pharmacological treatments. The purpose of this study was to compare the effectiveness of BWL versus dim red light therapy (DRL) on depressive symptoms within individual cancer survivors using personalized (N-of-1) trials. Methods: Cancer survivors with at least mild depressive symptoms were randomized to one of two treatment sequences consisti...
#2Gary R. Zirpoli (BU: Boston University)H-Index: 1
Last.Kathy S. Albain (LUC: Loyola University Chicago)H-Index: 59
view all 20 authors...
PURPOSEDespite reported widespread use of dietary supplements during cancer treatment, few empirical data with regard to their safety or efficacy exist. Because of concerns that some supplements, p...
#1Afsaneh Barzi (SC: University of Southern California)H-Index: 12
#2Dawn L. Hershman (CUMC: Columbia University Medical Center)H-Index: 58
Last.Joseph M. UngerH-Index: 39
view all 8 authors...
Summary To explore the rates of osteoporosis (diagnosis and screening) and fractures in colorectal cancer survivors (CRCS), records of clinical trial enrollees was linked to Medicare. Female/male risk of fracture in CRCS is 74% higher than general population. Less than 30% of male and female CRCS receive osteoporosis screening. Osteoporosis is a significant morbidity in CRCS.
#1Shing M. Lee (Columbia University)H-Index: 2
#2Jieling Miao (Fred Hutchinson Cancer Research Center)H-Index: 1
Last.Dawn L. Hershman (Columbia University)H-Index: 58
view all 6 authors...
Cancer treatments are associated with a multitude of adverse events (AEs). While both nurses and physicians are involved in patient care delivery and AE assessment, very few studies have examined the differences between nurses’ and physicians’ reporting and perception of AEs. An approach was recently proposed to assess treatment burden based on reported AEs from the physician’s perspective. In this paper, we use this approach to evaluate nurses’ perception of burden, and compare nurses’ and phys...
#1Madeleine B. Hopson (Columbia University)
#2Maika Onishi (Genentech)
Last.Kevin Kalinsky (Columbia University)H-Index: 13
view all 9 authors...
Abstract Introduction/Background Ovarian suppression from chemotherapy results in bone loss in premenopausal women with breast cancer (BC). Less is known about bone microarchitecture changes. We used high-resolution peripheral quantitative computed tomography (HR-pQCT) to measure volumetric bone density and trabecular and cortical microarchitecture in this population. Materials and Methods Premenopausal women with stage I-III BC undergoing adjuvant chemotherapy underwent a bone mineral density (...